# Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age

> **NCT00794144** · PHASE2 · COMPLETED · sponsor: **Alcon Research** · enrollment: 132 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Olopatadine Hydrochloride Nasal Spray 0.6%
- **DRUG:** Olopatadine Hydrochloride Nasal Spray Vehicle

## Key facts

- **NCT ID:** NCT00794144
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-12
- **Final completion:** —
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2010-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00794144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00794144, "Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age". Retrieved via AI Analytics 2026-08-24 from https://api.ai-analytics.org/clinical/NCT00794144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*